Excellence in Ophthalmology is a medical education programme designed to help improve patient care by providing training and professional development for the ophthalmic community in the UK. Organised and funded by Novartis and Alcon, as part of the Novartis commitment to ophthalmology, Excellence in Ophthalmology is guided by a steering committee of leading medical retina professionals. The programme includes:
Science: Research awards and training programmes
Service: Sharing of best practice service initiatives
Professional development: Specific skills development for ophthalmology professionals
Healthcare professionals who have attended Excellence in Ophthalmology events have commented:
“In one hour I have learned more about what has been holding up progress on my project at work than in six months working on it. Fantastic session”
“A must attend course if you want to optimise your chances of getting that next job.”
“Rarely do training courses focus on individuals’ needs so much.”
“Fantastic course - very informative and easy to relate to, very much in the contact of true life.”
Ophthalmologists and allied healthcare professionals can apply for relevant training courses after registering on the Excellence in Ophthalmology portal www.excellenceinophthalmology.co.uk.
Alcon (UK) Education Programme
Since its introduction, the Alcon (UK) Education Programme has benefited over 4000 ophthalmic healthcare professionals.
As part of Alcon's ongoing commitment to professional education and training, we are pleased to offer a number of fully accredited study days and courses for Ophthalmologists, Ophthalmic Nurses and Optometrists.
Alcon Eye Care UK Ltd are pleased to partner Novartis in its Excellence in Ophthalmology programme, which offers needs-based medical education, training and support for the ophthalmology community in the UK, designed to help optimise patient outcomes and experience.
Excellence in Ophthalmology is organised and funded by Novartis as part of their commitment to ophthalmology. It is a non-promotional programme and does not include promotional initiatives linked to Novartis products.